Renaissance BioScience’s novel RNA production and delivery technology receives Mexican patent: Vancouver, Canada Monday, December 8, 2025, 17:00 Hrs [IST] Renaissance BioScience ...

The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

The Allan Labor Government is supporting Melbourne researchers who have discovered a groundbreaking RNA treatment targeting rare childhood diseases ...

A new RNA type, smOOPs, has been found to drive biomolecular condensate formation in early development, offering new insight ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...

An update from Targovax ASA ( ($GB:0RIS) ) is now available. Circio Holding ASA has announced a proposed rights issue to raise up to NOK 50 ...

Researchers developed Bits2Bonds, a platform that merges molecular dynamics simulations with machine learning to design new ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

Cottonseeds could help reduce hunger and add new revenue for farmers. One researcher has been working for decades to make ...

An update from Oxford Nanopore Technologies PLC ( ($GB:ONT) ) is now available. Oxford Nanopore Technologies has engaged with major shareholders ...